SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2184271

Cover Image

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2184271

Diabetes Digital Therapeutics Market, By Diabetes Type, By Product Type, By Application, By End User, By Geography

PUBLISHED:
PAGES: 250 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4500
PDF & Excel (Multi User License - Up to 7 Users)
USD 7000
PDF & Excel (Corporate User License)
USD 10000

Add to Cart

Diabetes Digital Therapeutics Market is estimated to be valued at USD 1.84 Bn in 2026 and is expected to reach USD 4.37 Bn by 2033, growing at a compound annual growth rate (CAGR) of 13.2% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 1.84 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 13.20% 2033 Value Projection: USD 4.37 Bn

The global diabetes digital therapeutics market is the combination of digital health technology and evidence-based clinical interventions to prevent, manage, and treat diabetes. Solutions include mobile applications, AI-enabled therapeutic software, behavioral modification platforms, connected treatment systems and cloud-based monitoring tools that support diabetes management in conjunction with conventional therapies.

The global diabetes digital therapeutics market is expanding due to an increasing global prevalence of Type 1 and Type 2 diabetes, increasing healthcare expenditure, and need for continued patient engagement beyond clinical settings. Growing regulatory oversight, clinical validation, and the shift toward value-based care are further supporting the adoption of personalized, scalable, and cost-effective digital therapeutics for diabetes management worldwide.

Market Dynamics

The global diabetes digital therapeutics market is driven by the increasing incidence of diabetes worldwide, the increasing use of smartphones and wearable devices, and the growing need for continuous and personalized diabetes management. Advances in artificial intelligence, remote monitoring, and behavioral coaching are improving diabetes care, while increasing regulatory clarity and healthcare providers' focus on reducing complications and treatment costs are supporting market adoption.

However, the growth of diabetes digital therapeutics market is limited by factors such as concerns regarding data privacy, poor digital proficiency, inconsistent reimbursement policies, and difficulties in maintaining long-term patient engagement. Nevertheless, significant opportunities exist in emerging markets such as Asia Pacific, Latin America and Middle East & Africa with increasing digital infrastructure and awareness of diabetes. Strategic collaborations, integration with continuous glucose monitoring systems, and wider telehealth adoption are expected to further strengthen market growth.

Key Features of the Study

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global diabetes digital therapeutics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Better Therapeutics, Inc., Welldoc, Inc., Amalgam Rx, Inc., Hygieia, Inc., Voluntis S.A., DarioHealth Corp., Roche Diabetes Care GmbH, Sanofi S.A., Emperra GmbH E-Health Technologies, and Lilly USA, LLC
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global diabetes digital therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global diabetes digital therapeutics market

Market Segmentation

  • Diabetes Type Insights (Revenue, USD Bn, 2021 - 2033)
  • Type 1 Diabetes
  • Type 2 Diabetes
  • Prediabetes
  • Gestational Diabetes
  • Product Type Insights (Revenue, USD Bn, 2021 - 2033)
  • Software-Based Solutions
  • Device-Integrated Digital Therapeutics
  • Digital Therapeutic Platforms
  • Application Insights (Revenue, USD Bn, 2021 - 2033)
  • Glucose Management and Glycemic Control
  • Lifestyle and Behavioral Modification
  • Medication Adherence
  • Diabetes Self-Management Education
  • Insulin and Treatment Support
  • Others
  • End User Insights (Revenue, USD Bn, 2021 - 2033)
  • Hospitals and Healthcare Systems
  • Specialty Diabetes Clinics
  • Home Healthcare Providers
  • Employers and Health Plans
  • Others
  • Regional Insights (Revenue, USD Bn, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
  • Better Therapeutics, Inc.
  • Welldoc, Inc.
  • Amalgam Rx, Inc.
  • Hygieia, Inc.
  • Voluntis S.A.
  • DarioHealth Corp.
  • Roche Diabetes Care GmbH
  • Sanofi S.A.
  • Emperra GmbH E-Health Technologies
  • Lilly USA, LLC
Product Code: CMI10277

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Diabetes Digital Therapeutics Market, By Diabetes Type
    • Global Diabetes Digital Therapeutics Market, By Product Type
    • Global Diabetes Digital Therapeutics Market, By Application
    • Global Diabetes Digital Therapeutics Market, By End User
    • Global Diabetes Digital Therapeutics Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Diabetes Type Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Market Opportunities
  • Industry Trends

4. Global Diabetes Digital Therapeutics Market, By Diabetes Type, 2021-2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Type 1 Diabetes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Type 2 Diabetes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Prediabetes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Gestational Diabetes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

5. Global Diabetes Digital Therapeutics Market, By Product Type, 2021-2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Software-Based Solutions
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Device-Integrated Digital Therapeutics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Digital Therapeutic Platforms
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

6. Global Diabetes Digital Therapeutics Market, By Application, 2021-2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Glucose Management and Glycemic Control
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Lifestyle and Behavioral Modification
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Medication Adherence
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Diabetes Self-Management Education
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Insulin and Treatment Support
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

7. Global Diabetes Digital Therapeutics Market, By End User, 2021-2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Hospitals and Healthcare Systems
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Specialty Diabetes Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Home Healthcare Providers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Employers and Health Plans
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

8. Global Diabetes Digital Therapeutics Market, By Region, 2021 - 2033, Value (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Diabetes Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User,2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Diabetes Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User,2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Diabetes Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User,2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Diabetes Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User,2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Diabetes Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User,2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Diabetes Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User,2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
      • South Africa
      • North Africa
      • Central Africa

9. Competitive Landscape

  • Better Therapeutics, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Welldoc, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Amalgam Rx, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Hygieia, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Voluntis S.A.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • DarioHealth Corp.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Roche Diabetes Care GmbH
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Sanofi S.A.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Emperra GmbH E-Health Technologies
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Lilly USA, LLC
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

10. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About us
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!